Literature DB >> 20192727

Microscopic observation drug susceptibility assay for tuberculosis screening before isoniazid preventive therapy in HIV-infected persons.

Krishna P Reddy1, Mark F Brady, Robert H Gilman, Jorge Coronel, Marcos Navincopa, Eduardo Ticona, Gonzalo Chavez, Eduardo Sánchez, Christian Rojas, Lely Solari, Jorge Valencia, Yvett Pinedo, Carlos Benites, Jon S Friedland, David A J Moore.   

Abstract

BACKGROUND: Active tuberculosis (TB) must be excluded before initiating isoniazid preventive therapy (IPT) in persons infected with human immunodeficiency virus (HIV), but currently used screening strategies have poor sensitivity and specificity and high patient attrition rates. Liquid TB culture is now recommended for the detection of Mycobacterium tuberculosis in individuals suspected of having TB. This study compared the efficacy, effectiveness, and speed of the microscopic observation drug susceptibility (MODS) assay with currently used strategies for TB screening before IPT in HIV-infected persons.
METHODS: A total of 471 HIV-infected IPT candidates at 3 hospitals in Lima, Peru, were enrolled in a prospective comparison of TB screening strategies, including laboratory, clinical, and radiographic assessments.
RESULTS: Of 435 patients who provided 2 sputum samples, M. tuberculosis was detected in 27 (6.2%) by MODS culture, 22 (5.1%) by Lowenstein-Jensen culture, and 7 (1.6%) by smear. Of patients with any positive microbiological test result, a MODS culture was positive in 96% by 14 days and 100% by 21 days. The MODS culture simultaneously detected multidrug-resistant TB in 2 patients. Screening strategies involving combinations of clinical assessment, chest radiograph, and sputum smear were less effective than 2 liquid TB cultures in accurately diagnosing and excluding TB (P<.01). Screening strategies that included nonculture tests had poor sensitivity and specificity.
CONCLUSIONS: MODS culture identified and reliably excluded cases of pulmonary TB more accurately than other screening strategies, while providing results significantly faster than Lowenstein-Jensen culture. Streamlining of the ruling out of TB through the use of liquid culture-based strategies could help facilitate the massive up-scaling of IPT required to reduce HIV and TB morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192727      PMCID: PMC2947458          DOI: 10.1086/651081

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  32 in total

1.  Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis.

Authors:  Girum Shiferaw; Yimtubezinash Woldeamanuel; Mekdes Gebeyehu; Feven Girmachew; Daniel Demessie; Eshetu Lemma
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

2.  Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis.

Authors:  Mayra Arias; Fernanda C Q Mello; Ada Pavón; Anna Grazia Marsico; Carlos Alvarado-Gálvez; Senia Rosales; Carlos Leonardo Carvalho Pessôa; Melly Pérez; Monica K Andrade; Afranio L Kritski; Leila S Fonseca; Richard E Chaisson; Michael E Kimerling; Susan E Dorman
Journal:  Clin Infect Dis       Date:  2007-01-22       Impact factor: 9.079

3.  Microscopic-observation drug-susceptibility assay for the diagnosis of TB.

Authors:  David A J Moore; Carlton A W Evans; Robert H Gilman; Luz Caviedes; Jorge Coronel; Aldo Vivar; Eduardo Sanchez; Yvette Piñedo; Juan Carlos Saravia; Cayo Salazar; Richard Oberhelman; Maria-Graciela Hollm-Delgado; Doris LaChira; A Roderick Escombe; Jon S Friedland
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 91.245

4.  The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis: results of a multicenter prospective trial.

Authors:  A Catanzaro; S Perry; J E Clarridge; S Dunbar; S Goodnight-White; P A LoBue; C Peter; G E Pfyffer; M F Sierra; R Weber; G Woods; G Mathews; V Jonas; K Smith; P Della-Latta
Journal:  JAMA       Date:  2000-02-02       Impact factor: 56.272

5.  Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting.

Authors:  David A J Moore; Luz Caviedes; Robert H Gilman; Jorge Coronel; Fanny Arenas; Doris LaChira; Cayo Salazar; Juan Carlos Saravia; Richard A Oberhelman; Maria-Graciela Hollm-Delgado; A Roderick Escombe; Carlton A W Evans; Jon S Friedland
Journal:  Diagn Microbiol Infect Dis       Date:  2006-05-06       Impact factor: 2.803

6.  Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study.

Authors:  Alison D Grant; Salome Charalambous; Katherine L Fielding; John H Day; Elizabeth L Corbett; Richard E Chaisson; Kevin M De Cock; Richard J Hayes; Gavin J Churchyard
Journal:  JAMA       Date:  2005-06-08       Impact factor: 56.272

7.  Randomised controlled trial of isoniazid preventive therapy in South African adults with advanced HIV disease.

Authors:  A Mohammed; L Myer; R Ehrlich; R Wood; F Cilliers; G Maartens
Journal:  Int J Tuberc Lung Dis       Date:  2007-10       Impact factor: 2.373

8.  Screening for tuberculosis prior to isoniazid preventive therapy among HIV-infected gold miners in South Africa.

Authors:  J H Day; S Charalambous; K L Fielding; R J Hayes; G J Churchyard; A D Grant
Journal:  Int J Tuberc Lung Dis       Date:  2006-05       Impact factor: 2.373

Review 9.  Isoniazid preventive therapy and risk for resistant tuberculosis.

Authors:  Maria Elvira Balcells; Sara L Thomas; Peter Godfrey-Faussett; Alison D Grant
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

10.  Improvement of tuberculosis case detection and reduction of discrepancies between men and women by simple sputum-submission instructions: a pragmatic randomised controlled trial.

Authors:  Mishal Sameer Khan; Osman Dar; Charalambos Sismanidis; Karam Shah; Peter Godfrey-Faussett
Journal:  Lancet       Date:  2007-06-09       Impact factor: 79.321

View more
  7 in total

1.  Diagnosis of pulmonary tuberculosis in HIV-positive patients by microscopic observation drug susceptibility assay.

Authors:  Dang Thi Minh Ha; Nguyen Thi Ngoc Lan; Vo Sy Kiet; Marcel Wolbers; Hoang Thi Thanh Hang; Jeremy Day; Nguyen Quang Hien; Nguyen Anh Tien; Pham Thuy An; Truong Thi Anh; Do Thi Tuong Oanh; Chau Luong Hoa; Nguyen Thi Minh Chau; Nguyen Ngoc Hai; Ngo Thanh Binh; Le Hong Ngoc; Doan Thanh Phuong; Tran Van Quyet; Nguyen Thi Bich Tuyen; Vo Thi Ha; Nguyen Thi Nho; Dai Viet Hoa; Phan Thi Hoang Anh; Nguyen Huy Dung; Jeremy Farrar; Maxine Caws
Journal:  J Clin Microbiol       Date:  2010-10-06       Impact factor: 5.948

Review 2.  HIV and tuberculosis: a deadly human syndemic.

Authors:  Candice K Kwan; Joel D Ernst
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

Review 3.  Novel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfection.

Authors:  Asha Anandaiah; Keertan Dheda; Joseph Keane; Henry Koziel; David A J Moore; Naimish R Patel
Journal:  Am J Respir Crit Care Med       Date:  2010-12-22       Impact factor: 21.405

4.  Reliability of the MODS assay decentralisation process in three health regions in Peru.

Authors:  A Mendoza; E Castillo; N Gamarra; T Huamán; M Perea; Y Monroi; R Salazar; J Coronel; M Acurio; G Obregón; M Roper; C Bonilla; L Asencios; D A J Moore
Journal:  Int J Tuberc Lung Dis       Date:  2011-02       Impact factor: 2.373

Review 5.  Tuberculous meningitis in patients infected with human immunodeficiency virus.

Authors:  Ravindra Kumar Garg; Manish Kumar Sinha
Journal:  J Neurol       Date:  2010-09-17       Impact factor: 6.682

6.  High prevalence and low cure rate of tuberculosis among patients with HIV in Xinjiang, China.

Authors:  Rena Maimaiti; Yuexin Zhang; Kejun Pan; Peierdun Mijiti; Maimaitiali Wubili; Maimaitijiang Musa; Rune Andersson
Journal:  BMC Infect Dis       Date:  2017-01-05       Impact factor: 3.090

7.  Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe.

Authors:  Beauty Makamure; Jesca Mhaka; Salome Makumbirofa; Reggie Mutetwa; Lucy Mupfumi; Peter Mason; John Z Metcalfe
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.